Thirupathirao Jalagam1 , Kiran Madhala2 , Syam Sundar Junapudi3
BACKGROUND Metabolic Syndrome (MS) is a cluster of metabolic abnormalities wherein patients are obese and have hypertension, high triglyceride level, low high density lipoprotein, and abnormal fasting glucose levels.1,2 It is also known as Syndrome X. Metabolic syndrome is associated with the risk of developing cardiovascular disease and type 2 diabetes. The main objective of this study was to determine the prevalence of thyroid dysfunction among newly diagnosed metabolic syndrome patients. METHODS The study was conducted among patients attending the OPD of General Medicine Department, at Government General Hospital attached to Government Medical College, Nizamabad. This study was a hospital based cross-sectional study. Study was conducted for 1 year from April 2017 to April 2018. A convenient sample of 100 patients was taken in this study after applying inclusion and exclusion criteria. Patients who fulfilled the criteria for metabolic syndrome by IDF were included in the study after taking written informed consent. RESULTS In this study total 100 patients were included, 43 were males and 57 were females. Majority of patients 45 were in the 40 to 49 age group. 80 patients found to be euthyroid and 20 patients were with thyroid dysfunction. 4 patients were hypothyroid. 14 patients had Subclinical hypothyroidism and 2 patients had Subclinical hyperthyroidism. CONCLUSIONS In this study 100 patients were included, 43 were males and 57 were females. Majority of patients (45) were in the 40 to 49 years age group. According to American Thyroid Association and The Endocrine Society classification 80 patients were found to be euthyroid and 20 patients were with thyroid dysfunction. 4 patients were hypothyroid. 14 patients had subclinical hypothyroidism and 2 patients had subclinical hyperthyroidism in the present study.
